Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Common Equity (2016 - 2026)

Eastman Chemical (EMN) has disclosed Common Equity for 18 consecutive years, with $6.1 billion as the latest value for Q1 2026.

  • For Q1 2026, Common Equity rose 2.39% year-over-year to $6.1 billion; the TTM value through Mar 2026 reached $6.1 billion, up 2.39%, while the annual FY2025 figure was $6.0 billion, 3.16% up from the prior year.
  • Common Equity hit $6.1 billion in Q1 2026 for Eastman Chemical, up from $6.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $6.1 billion in Q1 2026 and bottomed at -$5.6 billion in Q2 2022.
  • Average Common Equity over 5 years is $5.0 billion, with a median of $5.7 billion recorded in 2024.
  • Year-over-year, Common Equity tumbled 192.44% in 2022 and then skyrocketed 196.05% in 2023.
  • Eastman Chemical's Common Equity stood at $5.2 billion in 2022, then increased by 5.61% to $5.5 billion in 2023, then rose by 5.82% to $5.9 billion in 2024, then increased by 3.16% to $6.0 billion in 2025, then rose by 0.81% to $6.1 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $6.1 billion, $6.0 billion, and $5.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.